首页>>国际

赵立坚:北约早已沦为美国维持霸权的工具

2022-06-28 23:50:40 | 来源:0lw新闻网
小字号

江津市品茶|喝茶约茶|联系方式赵立坚:北约早已沦为美国维持霸权的工具

6月28日报(bao)导 据“交际部讲话人(ren)办公(gong)室”微信公家号动静,在6月28日交际部例行记者会上,有(you)记(ji)者发问(wen):北约将在本周(zhou)提出的“计谋概念”文件(jian)中给中国(guo)贴上“系(xi)统性挑战”标签,同时强调中俄不竭深化的火伴关系。交际部对此有何回应?交际部(bu)讲话人赵立坚暗示,作为暗斗产品和全(quan)球最年(nian)夜军事同盟,北约(yue)持久固守陈腐(fu)的平安不雅念(nian),早已沦为个体国度保持(chi)霸权的东西。北约所谓新(xin)计谋文件,不外(wai)是新(xin)瓶装旧酒,本(ben)色上没有改变制造设想敌(di)、弄阵营匹敌的暗斗思惟。赵立坚指出,中国奉行自力自立的和平交际政策,不干与别国内(nei)政,不输出意识形态,更不弄长臂管辖、经济勒迫、单(dan)边制裁,何(he)谈系统性挑战?中方鞭策构建人类命(ming)运配合体,推动高质量共建“一带一路”,提出(chu)全球成长倡议(yi)、全球(qiu)平安倡议,为国际社会解决和平成长等重年夜问题供给了年夜(ye)量公共产物。中国的成长是全球的机(ji)缘,不是任何人(ren)的挑战。我们严明要(yao)求北约当即(ji)住手散布针对中方的不实之词和搬弄谈吐(tu)。北约应当做的是抛却暗斗(dou)思惟、零和博弈、制(zhi)造(zao)“仇敌”的做法,不要在弄乱欧洲以后,诡计再弄乱亚洲,弄乱全(quan)球。


(责编:admin)

分享让更多人看到

Asia Cell & Gene Therapy Innovation Summit 2022
  • #CGT Asia 2022
  • July 10th-11th
  • Shanghai China

Asia Cell & Gene Therapy Innovation Summit 2022

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Cell Therapy, Gene Therapy, Innovative Therapy, Next Generation Oncolytic Virus, End to End Development, CDMO, CRO, Regulation, IND Application, GLP, Clinical Trail Design, Continuous Production Process, GMP, Immunomodulation, Viral Vectors, High-Throughput Screening, Transfection, Combination Therapy, IVD, Digital PCR, CRISPR/CAS9 Gene Editing, Humanized Animal models, mRNA Tumor Vaccines, Nanoantibody, BsAbs, Customization Manufacturing, Tumor Microenvironment, Stem Cell Therapy, Recombinant Protein, Targets

Event Highlights

Cell Therapy Industrialization and Commercialization Module Strategy

TCR-T Therapy Market Prospects and Development Trends

Targets Selection and Direction of TCR-T Therapeutic Products

Development Key Points of Universal CAR-NK Cell Therapy Products

iPSC Personalized Diagnosis and Treatment and Application

Research and Development of mRNA Drug and Delivery Vector Technology

Viral Vector Process and Optimization Plan

Difficulty in the Development of Gene Therapy Drugs for Rare Diseases

Current Status of Circular RNA R&D

Who Should Attend

Biopharmaceutical CompaniesPre-Clinical R&DClinical R & DVaccine/Antibody CompaniesCell Therapy CompaniesGene Therapy CompaniesScientific Research InstitutesBiotechnology CompaniesLaboratory Equipment SuppliersDrug TestingAnalytical ServicesProduction Solution Providers (Upstream, Downstream) Life Science and Analytical EquipmentDiagnostic and Testing EquipmentExternal AuthorizationProtein Drugs CompaniesContract Service Providers (CRO, CMO, CDMO) Import and Export EnterprisesHVAC Facilities and Cleanroom Equipment SuppliersGovernment Representatives/Trading InstitutionsPreparation MachineryPharmaceutical EngineeringLaw and Regulation FirmsDrug Delivery System ManufacturersThird Party Logistics ProvidersAutomation/RobotCold Chain Packaging CompaniesPackaging MachineryIndustrial ParksLaboratory ServicesLaboratory/Biochemical/Analytical InstrumentsFine Chemical ManufacturersEnvironmental ProtectionIntermediate ManufacturersRegulatory ServicesSupply ChainNew Drug R & D CompaniesConsultant Companies


Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show


Speakers

Hongjiu DAI
Hongjiu DAI

CEO

Nanjing Kaedi Biotherapeutics

Prof. Evelyne Yehudit Bischof
Prof. Evelyne Yehudit Bischof

Professor Doctor

Shanghai University of Medicine and Health Sciences

Yongzhen LIU
Yongzhen LIU

Deputy Director of Center for Drug Safety Evaluation

Shanghai Institute of Materia Medica

Ryan CAWOOD
Ryan CAWOOD

Chief Scientific Officer

WuXi Advanced Therapies

 Lei ZHANG
Lei ZHANG

R&D VP

Neukio Biotherapeutics

Jimin GAO
Jimin GAO

Professor

Wenzhou Medical University

Ke ZHANG
Ke ZHANG

Chief Scientific Officer

SCG Cell

Yun YANG
Yun YANG

CTO

CirCode Bio

Yang WANG
Yang WANG

Director of Research and Development

Wuhan Binhui Biopharmaceutical

Xiaoxi XU
Xiaoxi XU

Director of In Vitro

Crown Bioscience

Mark FANG
Mark FANG

CQO

Shanghai Zhimi Medical Technology

Adam ZHAO
Adam ZHAO

President

AnlongBio

Yunxiang ZHU
Yunxiang ZHU

Vice President

CANbridge Pharma

Frank GAO
Frank GAO

Chief Strategy Officer

BRL Medicine

Tianhong XU
Tianhong XU

CEO

Base Therapeutics

Emily TAN
Emily TAN

Chief Operating Officer

Bennu Biotherapeutics

Tomas KOSTELEC
Tomas KOSTELEC

CSO

BIA Separations

Fred MAO
Fred MAO

Partner & Managing Director

Frost & Sullivan

Yarong LIU
Yarong LIU

Founder

Grit Biotechnology

Lei SUN
Lei SUN

CTO

GeneMind

John LU
John LU

President & CEO

HebeCell

Yi ZHU
Yi ZHU

Chief Executive Officer

Hillgene

Grace Zhou
Grace Zhou

CEO

ImmVira Pharma

Xiaoqi QI
Xiaoqi QI

Associate Regional Marketing Manager

10x Genomics

Alex CHENG
Alex CHENG

General Manager

Shanghai Tofflon Medical Equipment

Dijing XU
Dijing XU

Senior Field Application Scientist

IsoPlexis

Jim LIU
Jim LIU

G. China Senior Training Manager

Miltenyi Biotec

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

( Slots Limited)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at CGT Asia our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Media Partners

今日头条
搜狐
药智网
医谷网
CPHI制药在线
会会药咖
镁客网
化学加
人民医生网
研发客
肽度
大健康派
生物探索
药源网
基因线上
转化医学网
现代健康网
医药健闻
中国制药设备网
环球财经
商业观察网
医诺医学
美通社
动脉网
医疗器械创新网
化学网
中国仪器批发网
再生医学
盖德化工网
大健康网
阿仪网
张通社
测序宝
基因君
51健康网
中国健康咨询网
爱爱医
来宝网
露森科研
生物通
医学信息
中国生物器材网
分析测试百科网
全球医学会议网

Related Meetings